Honeybul S
Department of Neurosurgery, Sir Charles Gairdner Hospital and Royal Perth Hospital, Hospital Avenue, Perth, WA 6000, Australia.
J Clin Neurosci. 2016 Jun;28:12-5. doi: 10.1016/j.jocn.2016.01.002. Epub 2016 Feb 28.
Over the past two decades there has been considerable interest in the use of hypothermia in the management of severe traumatic brain injury. However despite promising experimental evidence, results from clinical studies have failed to demonstrate benefit. Indeed recent studies have shown a tendency to worse outcomes in those patients randomised to therapeutic hypothermia. In this narrative review the pathophysiological rationale behind hypothermia and the clinical evidence for efficacy are examined. There would still appear to be a role for hypothermia in the management of intractable intracranial hypertension. However optimising therapeutic time frames and better management of strategies for complications will be required if experimental evidence for neuroprotection is to be translated into clinical benefit.
在过去二十年里,人们对低温疗法用于严重创伤性脑损伤的治疗产生了浓厚兴趣。然而,尽管有前景良好的实验证据,但临床研究结果未能证明其益处。事实上,最近的研究表明,随机接受治疗性低温疗法的患者有预后更差的趋势。在这篇叙述性综述中,我们研究了低温疗法背后的病理生理原理以及其疗效的临床证据。低温疗法在治疗顽固性颅内高压方面似乎仍能发挥作用。然而,如果要将神经保护的实验证据转化为临床益处,就需要优化治疗时间框架并更好地管理并发症的应对策略。